Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids
Overview
We assume that the combination of systemic steroids and inhaled steroid in the first hour of treatment in the ER will decrease the admission rate and improve faster the pulmonary function. 120 patients refferd to the ER due to asthma attack aged 18-60 with PFR < 60% 0o predicted will participate in the study after giving informed consent. The usual treatment in the ER is inhalation of Beta 2 short acting and I.V solumedrol 120 mg . The study group will recieve in addition 3 inhalation of Budesonide 1000 microgram each during the first hour. The controlled group will recieve Nacl 0.9% PFR will be followed 0 30 60 120 min.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
Detailed Description
Primary end points- PFT improvment and admission rate.
Interventions
- Drug: inhalation of corticosteroids
Clinical Trial Outcome Measures
Primary Measures
- PFT improvment
- Admission rate
Participating in This Clinical Trial
Inclusion Criteria
- Asthmatic patients aged 18-60 with PFR < 60% of predicted Exclusion Criteria:
- Patients with other chronic diseases – cardiac renal hepatic etc will be excluded
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 60 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Soroka University Medical Center
- Overall Official(s)
- Dov Heimer, M.D, Principal Investigator, BGU Soroka medical center
- Overall Contact(s)
- Dov Heimer M.D. Heimer, AS. Proffessor, 972 8 6400807, heimerd@clalit.org.il
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.